Home / Tag Archives: Amicus Therapeutics

Tag Archives: Amicus Therapeutics

Skin Disease Tx Abandoned by Developer

skin disease

Development of the novel treatment for the skin disease epidermolysis bullosa will be discontinued, Amicus Therapeutics, Inc announced. The SD-101 treatment for the rare genetic disease failed to meet primary endpoints in a late-stage trial, Reuters reported, after similar rates of treatment participants achieved wound healing as did placebo. Instead, the drug developer plans to focus on …

Read More »